Suchergebnisse

PubPharm (6.794)

1

A structural model for the coevolution of networks and behavior

enthalten in: The review of economics and statistics | 2022

von Hsieh, C. | König, M. | Liu, X.

2

Joining forces to prevent the antibiotic resistance doomsday scenario : the rise of international multisectoral partnerships as a new governance model

enthalten in: Academy of Management perspectives | 2020

von Ciabuschi, F. | Baraldi, E. | Lindahl, O.

3

Managing and preparing for emerging infectious diseases : avoiding a catastrophe

enthalten in: Academy of Management perspectives | 2020

von Pereira, V. | Temouri, Y. | Patnaik, S. | +1

4

Persuading the principal to wait

enthalten in: Journal of political economy | 2020

von Orlov, D. | Skrzypacz, A. | Zryumov, P.

5

The distribution of surplus in the US pharmaceutical industry : evidence from paragraph iv patent-litigation decisions

enthalten in: The journal of law & economics | 2020

von Jacobo-Rubio, R. | Turner, J. | Williams, J.

6

Research and the approval process : the organization of persuasion

enthalten in: The American economic review | 2019

von Henry, E. | Ottaviani, M.

7

Artificial intelligence and economic growth

enthalten in: The economics of artificial intelligence | 2019

von Aghion, P. | Jones, B. | Jones, C.

8

Preventives versus treatments redux : tighter bounds on distortions in innovation incentives with an application to the global demand for HIV pharmaceuticals

enthalten in: Review of industrial organization | 2018

von Kremer, M. | Snyder, C.

9

Who (if anyone) should be liable for injuries from generic drugs?

enthalten in: The journal of law, economics, & organization | August 2017

von Friedman, E. | Wickelgren, A.

10

Baumol's cost disease and the sustainability of the welfare state

enthalten in: Economica | July 2017

von Andersen, T. | Kreiner, C.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[680]